Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-01-19

Clinical Trial Update: Metabolic Effects of Metformin Therapy in Obstructive Sleep Apnea [Phase 1, Phase 2]

View source ↗

Summary

A terminated Phase 1/2 trial evaluating metabolic effects of metformin in obstructive sleep apnea. No results posted in snippet.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • metformin (metformin)

Snippet

Sponsor: Pennington Biomedical Research Center | Conditions: Sleep Apnea, Obstructive | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2023-01-19